Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2142380rdf:typepubmed:Citationlld:pubmed
pubmed-article:2142380lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2142380lifeskim:mentionsumls-concept:C0013080lld:lifeskim
pubmed-article:2142380lifeskim:mentionsumls-concept:C0235946lld:lifeskim
pubmed-article:2142380lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:2142380pubmed:issue4lld:pubmed
pubmed-article:2142380pubmed:dateCreated1990-8-13lld:pubmed
pubmed-article:2142380pubmed:abstractTextIndividuals with Down syndrome develop neuropathologic and in some cases clinical evidence of Alzheimer disease after age 40. We compared CT scans of 18 Down syndrome subjects, 26-70 years old (seven of whom satisfied criteria for dementia), with 175 screened normal volunteer control subjects for evidence of cortical and subcortical atrophy. CT scans were analyzed as a function of age and cognitive status. The suprasellar cistern ratio, presumed to measure mesial temporal-lobe atrophy (or hypoplasia), was correlated with severity of cognitive impairment, even when age effects were removed. The suprasellar cistern ratio predicted dementia status with an accuracy of greater than 75%. Brain measurements on CT scans showed a distinct pattern of increased abnormality with age in patients with Down syndrome; this differed clearly from that seen in controls.lld:pubmed
pubmed-article:2142380pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2142380pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2142380pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2142380pubmed:languageenglld:pubmed
pubmed-article:2142380pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2142380pubmed:citationSubsetIMlld:pubmed
pubmed-article:2142380pubmed:statusMEDLINElld:pubmed
pubmed-article:2142380pubmed:issn0195-6108lld:pubmed
pubmed-article:2142380pubmed:authorpubmed-author:DIXONN FNFlld:pubmed
pubmed-article:2142380pubmed:authorpubmed-author:FolsteinM FMFlld:pubmed
pubmed-article:2142380pubmed:authorpubmed-author:KumarA JAJlld:pubmed
pubmed-article:2142380pubmed:authorpubmed-author:PearlsonG DGDlld:pubmed
pubmed-article:2142380pubmed:authorpubmed-author:WarrenA CAClld:pubmed
pubmed-article:2142380pubmed:authorpubmed-author:StarksteinS...lld:pubmed
pubmed-article:2142380pubmed:authorpubmed-author:AylwardE HEHlld:pubmed
pubmed-article:2142380pubmed:issnTypePrintlld:pubmed
pubmed-article:2142380pubmed:volume11lld:pubmed
pubmed-article:2142380pubmed:ownerNLMlld:pubmed
pubmed-article:2142380pubmed:authorsCompleteYlld:pubmed
pubmed-article:2142380pubmed:pagination811-6lld:pubmed
pubmed-article:2142380pubmed:dateRevised2008-2-14lld:pubmed
pubmed-article:2142380pubmed:meshHeadingpubmed-meshheading:2142380-...lld:pubmed
pubmed-article:2142380pubmed:meshHeadingpubmed-meshheading:2142380-...lld:pubmed
pubmed-article:2142380pubmed:meshHeadingpubmed-meshheading:2142380-...lld:pubmed
pubmed-article:2142380pubmed:meshHeadingpubmed-meshheading:2142380-...lld:pubmed
pubmed-article:2142380pubmed:meshHeadingpubmed-meshheading:2142380-...lld:pubmed
pubmed-article:2142380pubmed:meshHeadingpubmed-meshheading:2142380-...lld:pubmed
pubmed-article:2142380pubmed:meshHeadingpubmed-meshheading:2142380-...lld:pubmed
pubmed-article:2142380pubmed:meshHeadingpubmed-meshheading:2142380-...lld:pubmed
pubmed-article:2142380pubmed:meshHeadingpubmed-meshheading:2142380-...lld:pubmed
pubmed-article:2142380pubmed:meshHeadingpubmed-meshheading:2142380-...lld:pubmed
pubmed-article:2142380pubmed:articleTitleBrain atrophy in 18 patients with Down syndrome: a CT study.lld:pubmed
pubmed-article:2142380pubmed:affiliationDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD 21205.lld:pubmed
pubmed-article:2142380pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2142380pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2142380pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed